BIOVEGEN General Assembly held

Last Thursday BIOVEGEN held a new meeting of its General Assembly. The meeting also included the session “Technological trends and financing for plant R&D&I” in which future applications in the genome editing market and the financing opportunities for the plant innovation sector that they open were addressed. the NEXT GENERATION EU funds. During the subsequent Colloquium, BIOVEGEN partners had the opportunity to ask the speakers their questions.

Order of the day:

11:00 a.m. Welcome and introduction
11:10 a.m. BIOVEGEN General Assembly

• Reading Minutes of the previous Assembly
• Ratification of new members
• Activities Report and Action Plan 2021-2022
• Economic situation and Budget 2021-2022
• Various matters
• Requests and questions

12:00 p.m. Session “Technological trends and financing for plant R&D&I”

• Genome editing: future applications in international markets. Emilio RodríguezCerezo. Joint Research Centre, European Commission.
• Financing for plant innovation. NEXT GENERATION Funds, PERTE AGRO. Luis Socías Uribe. European Projects Office, CEOE.

12:50 p.m. Colloquium with BIOVEGEN partners